IRADIMED CORPORATION Capital Expenditures
IRADIMED CORPORATION (IRMD) reported Capital Expenditures of $588.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-31.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-07-31
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $185.00K, a 92.98% decline year-over-year.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $403.00K, a 89.10% decline year-over-year.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $294.17K, a 89.46% decline year-over-year.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $1.14M, a 70.14% decline year-over-year.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for fiscal 2025 was $7.76M, a 3.00% decline from fiscal 2024.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for fiscal 2024 was $8.01M, a 7.59% increase from fiscal 2023.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for fiscal 2023 was $7.44M, a 804.05% increase from fiscal 2022.
- IRADIMED CORPORATION payments to acquire property, plant, and equipment for fiscal 2022 was $823.02K, a 70.64% increase from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 3 month as first filed | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $185.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $588.00K 10-Q · filed 2026-07-31 | $882.17K derived: sum of 3 quarters · filed 2026-07-31 | $2.02M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2026-03-31 | $403.00K 10-Q · filed 2026-05-01 | $697.17K derived: sum of 2 quarters · filed 2026-05-01 | $1.83M derived: sum of 3 quarters · filed 2026-05-01 | $4.47M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-12-31 | $294.17K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $1.43M derived: sum of 2 quarters · filed 2026-03-06 | $4.07M derived: sum of 3 quarters · filed 2026-07-31 | $7.76M 10-K · filed 2026-03-06 | |||
| 2025-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $3.77M derived: sum of 2 quarters · filed 2026-07-31 | $7.47M 10-Q · filed 2025-11-03 | $10.26M derived: sum of 4 quarters · filed 2026-07-31 | |||
| 2025-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-31 | $6.33M 10-Q · filed 2026-07-31 | $6.33M 10-Q · filed 2025-08-01 | $9.12M derived: sum of 3 quarters · filed 2026-07-31 | $12.93M derived: sum of 4 quarters · filed 2026-07-31 | ||
| 2025-03-31 | $3.70M 10-Q · filed 2026-05-01 | $3.70M 10-Q · filed 2025-05-05 | $6.49M derived: sum of 2 quarters · filed 2026-05-01 | $10.30M derived: sum of 3 quarters · filed 2026-05-01 | $11.43M derived: sum of 4 quarters · filed 2026-05-01 | ||
| 2024-12-31 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06 | $6.60M derived: sum of 2 quarters · filed 2026-03-06 | $7.73M derived: sum of 3 quarters · filed 2026-03-06 | $8.01M 10-K · filed 2026-03-06 | $8.01M 10-K · filed 2025-03-06 | ||
| 2024-09-30 | $3.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $4.94M derived: sum of 2 quarters · filed 2025-11-03 | $5.21M 10-Q · filed 2025-11-03 | $5.75M derived: sum of 4 quarters · filed 2025-11-03 | |||
| 2024-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $1.40M 10-Q · filed 2025-08-01 | $1.94M derived: sum of 3 quarters · filed 2025-09-03 | $2.24M derived: sum of 4 quarters · filed 2025-09-03 | |||
| 2024-03-31 | $270.57K 10-Q · filed 2025-05-05 | $802.47K derived: sum of 2 quarters · filed 2025-09-03 | $1.11M derived: sum of 3 quarters · filed 2025-09-03 | $1.32M derived: sum of 4 quarters · filed 2025-09-03 | |||
| 2023-12-31 | $531.90K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-03 | $839.99K derived: sum of 2 quarters · filed 2025-09-03 | $1.04M derived: sum of 3 quarters · filed 2025-09-03 | $7.44M 10-K/A · filed 2025-09-03 | |||
| 2023-09-30 | $308.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $512.68K derived: sum of 2 quarters · filed 2024-10-31 | $6.91M 10-Q · filed 2024-10-31 | $7.17M derived: sum of 4 quarters · filed 2024-10-31 | |||
| 2023-06-30 | $204.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $6.60M 10-Q · filed 2024-08-01 | $6.86M derived: sum of 3 quarters · filed 2024-08-01 | $7.05M derived: sum of 4 quarters · filed 2024-08-01 | |||
| 2023-03-31 | $6.40M 10-Q · filed 2024-05-02 | $6.65M derived: sum of 2 quarters · filed 2024-05-02 | $6.85M derived: sum of 3 quarters · filed 2024-05-02 | $7.04M derived: sum of 4 quarters · filed 2024-05-02 | |||
| 2022-12-31 | $258.14K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | $451.08K derived: sum of 2 quarters · filed 2024-03-01 | $639.67K derived: sum of 3 quarters · filed 2024-03-01 | $823.02K 10-K · filed 2024-03-01 | |||
| 2022-09-30 | $192.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $381.53K derived: sum of 2 quarters · filed 2023-11-03 | $564.88K 10-Q · filed 2023-11-03 | $655.90K derived: sum of 4 quarters · filed 2023-11-03 | |||
| 2022-06-30 | $188.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $371.94K 10-Q · filed 2023-08-03 | $462.96K derived: sum of 3 quarters · filed 2023-08-03 | $613.72K derived: sum of 4 quarters · filed 2023-08-03 | |||
| 2022-03-31 | $183.35K 10-Q · filed 2023-05-04 | $274.37K derived: sum of 2 quarters · filed 2023-05-04 | $425.13K derived: sum of 3 quarters · filed 2023-05-04 | $533.36K derived: sum of 4 quarters · filed 2023-05-04 | |||
| 2021-12-31 | $91.02K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $241.78K derived: sum of 2 quarters · filed 2023-03-02 | $350.01K derived: sum of 3 quarters · filed 2023-03-02 | $482.32K 10-K · filed 2023-03-02 | |||
| 2021-09-30 | $150.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $258.99K derived: sum of 2 quarters · filed 2022-11-03 | $391.30K 10-Q · filed 2022-11-03 | $485.02K derived: sum of 4 quarters · filed 2022-11-03 | |||
| 2021-06-30 | $108.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $240.54K 10-Q · filed 2022-08-05 | $334.26K derived: sum of 3 quarters · filed 2022-08-05 | $382.99K derived: sum of 4 quarters · filed 2022-08-05 | |||
| 2021-03-31 | $132.32K 10-Q · filed 2022-05-06 | $226.04K derived: sum of 2 quarters · filed 2022-05-06 | $274.76K derived: sum of 3 quarters · filed 2022-05-06 | $408.73K derived: sum of 4 quarters · filed 2022-05-06 | |||
| 2020-12-31 | $93.72K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $142.44K derived: sum of 2 quarters · filed 2022-03-04 | $276.41K derived: sum of 3 quarters · filed 2022-03-04 | $443.00K 10-K · filed 2022-03-04 | |||
| 2020-09-30 | $48.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $182.69K derived: sum of 2 quarters · filed 2021-11-05 | $349.28K 10-Q · filed 2021-11-05 | $521.20K derived: sum of 4 quarters · filed 2022-03-04 | |||
| 2020-06-30 | $133.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $300.56K 10-Q · filed 2021-08-06 | $472.47K derived: sum of 3 quarters · filed 2022-03-04 | $549.88K derived: sum of 4 quarters · filed 2022-03-04 | |||
| 2020-03-31 | $166.59K 10-Q · filed 2021-05-07 | $338.50K derived: sum of 2 quarters · filed 2022-03-04 | $415.91K derived: sum of 3 quarters · filed 2022-03-04 | $451.93K derived: sum of 4 quarters · filed 2022-03-04 | |||
| 2019-12-31 | $171.91K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $249.32K derived: sum of 2 quarters · filed 2022-03-04 | $285.34K derived: sum of 3 quarters · filed 2022-03-04 | $368.28K 10-K · filed 2022-03-04 | |||
| 2019-09-30 | $77.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $113.43K derived: sum of 2 quarters · filed 2020-11-06 | $196.37K 10-Q · filed 2020-11-06 | $274.07K derived: sum of 4 quarters · filed 2021-03-05 | |||
| 2019-06-30 | $36.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $118.96K 10-Q · filed 2020-08-06 | $196.67K derived: sum of 3 quarters · filed 2021-03-05 | $241.95K derived: sum of 4 quarters · filed 2021-03-05 | |||
| 2019-03-31 | $82.94K 10-Q · filed 2020-05-07 | $160.65K derived: sum of 2 quarters · filed 2021-03-05 | $205.93K derived: sum of 3 quarters · filed 2021-03-05 | $273.27K derived: sum of 4 quarters · filed 2021-03-05 | |||
| 2018-12-31 | $77.71K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-05 | $122.99K derived: sum of 2 quarters · filed 2021-03-05 | $190.33K derived: sum of 3 quarters · filed 2021-03-05 | $228.31K 10-K · filed 2021-03-05 | |||
| 2018-09-30 | $45.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $112.63K derived: sum of 2 quarters · filed 2019-11-07 | $150.61K 10-Q · filed 2019-11-07 | $273.01K derived: sum of 4 quarters · filed 2020-03-06 | |||
| 2018-06-30 | $67.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $105.33K 10-Q · filed 2019-08-07 | $227.73K derived: sum of 3 quarters · filed 2020-03-06 | $469.70K derived: sum of 4 quarters · filed 2020-03-06 | |||
| 2018-03-31 | $37.98K 10-Q · filed 2019-05-08 | $160.39K derived: sum of 2 quarters · filed 2020-03-06 | $402.36K derived: sum of 3 quarters · filed 2020-03-06 | $573.16K derived: sum of 4 quarters · filed 2020-03-06 | |||
| 2017-12-31 | $122.40K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $364.37K derived: sum of 2 quarters · filed 2020-03-06 | $535.17K derived: sum of 3 quarters · filed 2020-03-06 | $775.57K 10-K · filed 2020-03-06 | |||
| 2017-09-30 | $241.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $412.77K derived: sum of 2 quarters · filed 2018-11-07 | $653.17K 10-Q · filed 2018-11-07 | $886.89K derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-06-30 | $170.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $411.20K 10-Q · filed 2018-08-08 | $644.92K derived: sum of 3 quarters · filed 2019-03-07 | $767.96K derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2017-03-31 | $240.40K 10-Q · filed 2018-05-08 | $474.12K derived: sum of 2 quarters · filed 2019-03-07 | $597.16K derived: sum of 3 quarters · filed 2019-03-07 | $821.87K derived: sum of 4 quarters · filed 2019-03-07 | |||
| 2016-12-31 | $233.72K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $356.76K derived: sum of 2 quarters · filed 2019-03-07 | $581.47K derived: sum of 3 quarters · filed 2019-03-07 | $780.81K 10-K · filed 2019-03-07 | |||
| 2016-09-30 | $123.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | $347.75K derived: sum of 2 quarters · filed 2017-11-06 | $547.09K 10-Q · filed 2017-11-06 | $652.44K derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-06-30 | $224.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $424.05K 10-Q · filed 2017-08-04 | $529.40K derived: sum of 3 quarters · filed 2018-03-08 | $601.36K derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2016-03-31 | $199.34K 10-Q · filed 2017-05-05 | $304.69K derived: sum of 2 quarters · filed 2018-03-08 | $376.65K derived: sum of 3 quarters · filed 2018-03-08 | $457.77K derived: sum of 4 quarters · filed 2018-03-08 | |||
| 2015-12-31 | $105.36K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $177.31K derived: sum of 2 quarters · filed 2018-03-08 | $258.43K derived: sum of 3 quarters · filed 2018-03-08 | $298.72K 10-K · filed 2018-03-08 | |||
| 2015-09-30 | $71.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $153.07K derived: sum of 2 quarters · filed 2016-11-04 | $193.37K 10-Q · filed 2016-11-04 | $272.84K derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2015-06-30 | $81.12K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $121.42K 10-Q · filed 2016-08-05 | $200.89K derived: sum of 3 quarters · filed 2017-03-10 | $486.97K derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2015-03-31 | $40.29K 10-Q · filed 2016-05-06 | $119.77K derived: sum of 2 quarters · filed 2017-03-10 | $405.85K derived: sum of 3 quarters · filed 2017-03-10 | $619.98K derived: sum of 4 quarters · filed 2017-03-10 | |||
| 2014-12-31 | $79.47K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $365.55K derived: sum of 2 quarters · filed 2017-03-10 | $579.68K derived: sum of 3 quarters · filed 2017-03-10 | $583.98K 10-K · filed 2017-03-10 | |||
| 2014-09-30 | $286.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $500.21K derived: sum of 2 quarters · filed 2015-11-10 | $504.50K 10-Q · filed 2015-11-10 | $546.50K derived: sum of 4 quarters · filed 2015-11-10 | |||
| 2014-06-30 | $214.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $218.43K 10-Q · filed 2015-08-11 | $260.43K derived: sum of 3 quarters · filed 2015-08-11 | $343.41K derived: sum of 4 quarters · filed 2015-08-11 | |||
| 2014-03-31 | $4.29K 10-Q · filed 2015-05-11 | $46.29K derived: sum of 2 quarters · filed 2015-05-11 | $129.28K derived: sum of 3 quarters · filed 2015-05-11 | ||||
| 2013-12-31 | $42.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-23 | $124.99K derived: sum of 2 quarters · filed 2015-03-23 | $163.18K 10-K · filed 2015-03-23 | ||||
| 2013-09-30 | $82.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | $121.17K 10-Q · filed 2014-11-13 | |||||
| 2013-06-30 | $38.19K 10-Q · filed 2014-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |